Prof. Dr. Lydia Meder



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Inhibition of Tumor VEGFR2 Induces Serine 897 EphA2-Dependent Tumor Cell Invasion and Metastasis in NSCLC (2020) Volz C, Breid S, Selenz C, Zaplatina A, Golfmann K, Meder L, Dietlein F, et al. Journal article Pretreatment Vitamin D deficiency is associated with impaired progression-free and overall survival in hodgkin lymphoma (2019) Borchmann S, Cirillo M, Goergen H, Meder L, Sasse S, Kreissl S, Broeckelmann PJ, et al. Journal article Preclinical studies reveal that LSD1 inhibition results in tumor growth arrest in lung adenocarcinoma independently of driver mutations (2018) Macheleidt IF, Dalvi PS, Lim SY, Meemboor S, Meder L, Kaesgen O, Mueller M, et al. Journal article Synergistic anti-angiogenic treatment effects by dual FGFR1 and VEGFR1 inhibition in FGFR1-amplified breast cancer (2018) Golfmann K, Meder L, Koker M, Volz C, Borchmann S, Tharun L, Dietlein F, et al. Journal article Combined VEGF and PD-L1 blockade displays synergistic treatment effects in an autochthonous mouse model of small cell lung cancer (2018) Meder L, Schuldt P, Thelen M, Schmitt A, Dietlein F, Klein S, Borchmann S, et al. Journal article LIN28B enhanced tumorigenesis in an autochthonous KRASG12V-driven lung carcinoma mouse model (2018) Meder L, Koenig K, Dietlein F, Macheleidt I, Florin A, Ercanoglu MS, Rommerscheidt-Fuss U, et al. Journal article Notch signaling triggers the tumor heterogeneity of small cell lung cancer (2017) Meder L, Buettner R, Odenthal M Journal article Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancer (2016) Latteyer S, Tiedje V, Koenig K, Ting S, Heukamp LC, Meder L, Schmid KW, et al. Journal article Heterogeneous mechanisms of primary and acquired resistance to third-generation EGFR inhibitors (2016) Ortiz-Cuaran S, Scheffler M, Plenker D, Dahmen I, Scheel AH, Fernandez-Cuesta L, Meder L, et al. Journal article NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas (2016) Meder L, Koenig K, Ozretic L, Schultheis AM, Ueckeroth F, Ade CP, Albus K, et al. Journal article
1 2 3